The Impact of the Hamilton Rating Scale for Depression on the Development of a Center for Clinical Psychopharmacology Research

  • L. Conti
  • G. B. Cassano
Conference paper
Part of the Psychopharmacology Series book series (PSYCHOPHARM, volume 9)

Abstract

All of us who had the opportunity of meeting Max Hamilton were agreeably surprised by his sense of moderation matched by his sense of humour. In spite of the widespread use made of the rating scales he created, and the fact that they are generally accepted as standard reference instruments, and in spite of the important role that these rating scales have had, not only on psychopharmacology but also in the fields of research and of clinical practice, he always retained a critical attitude. His philosophy and modesty are clearly shown by a sentence he used frequently: “I always check and firstly I check myself.”

Keywords

Placebo Fatigue Hydrate Depression Neurol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amin MM, Ananth JV, Coleman BS, Dacourt G, Farkas T, Goldstein B, Lapierre YD, Paykel E, Wakelin JS (1984) Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study. Clin Neuropharmacol 7 (s): 312–319CrossRefGoogle Scholar
  2. Cassano GB, Conti L (1981) Some considerations on the role of benzodiazepines in the treatment of depression. Br J Clin Pharmacol 11 (s): 23–29Google Scholar
  3. Cassano GB, Castrogiovanni P, Conti L (1973) Drug responses in different anxiety states under benzodiazepine treatment. Some multivariate analyses for the evaluation of “Rating Scale for Depression” scores. In: Garattini S (ed) The benzodiazepines. Raven New York, pp 379–390Google Scholar
  4. Cassano GB, Castrogiovani P, Conti L, Nardini AG, Viola L (1974) Recognition and treatment of depressive symptoms by non-psychiatrists. In: Kielholz P (ed) Depression in everyday practice. Huber, Berne, pp 174–183Google Scholar
  5. Cassano GB, Conti L, Massimetti G, Mauri M, dell’Osso L (1985) CCPDD - un centro per la documentazione dei dati in psicofarmacologica clinica. Riv Psichiatr 20: 1–17Google Scholar
  6. Cassano GB, Conti L, Massimetti G, Mengali F, Wakelin JS, Levine J (1986) Use of a standardized documentation system ( BLIPS/BDP) in the conduct of a multicenter international trial comparing fluvoxamine, imipramine and placebo. Psychopharmacol Bull 22: 52–58Google Scholar
  7. Conti L (1989) Predictors of response to fluvoxamine. ECNP Congress, May 24–26, GothenburgGoogle Scholar
  8. Dell’Osso L, Conti L, Cassano GB (1988) Imipramine, fluvoxamine and placebo: responders vs non-responders. AEP Meeting “Predictive factors of psychopharmacological response,” Palma de MajorcaGoogle Scholar
  9. Gallevi M, Castrogiovanni P, Cassano GB (1967) Efficacia del Ro 4–5360 ( Mogadon) nel trattamento degli stati ansiosi. Doppia prova cieca. Atti la Riunione Nazionale della Società Italiana di Neuropsicofarmacologia, NapoliGoogle Scholar
  10. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62PubMedCrossRefGoogle Scholar
  11. Hamilton M (1978) Les échelles d’appreciation dans la dépression: état actuel. In: Pichot P, Pull C (eds) La symptomatologie dépressive. Spires, Paris, pp 9–11Google Scholar
  12. Sarteschi P, Cassano GB, Castrogiovanni P, Conti L (1973) The use of rating scales for computer analysis of the affective symptoms in old age. Compr Psychiatry 14: 371–379PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • L. Conti
    • 1
  • G. B. Cassano
    • 1
  1. 1.Institute of Clinical PsychiatryUniversity of PisaPisaItaly

Personalised recommendations